EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.3.1.15 | Acquired Immunodeficiency Syndrome |
15878874 |
Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs. |
ongoing research unassigned |
4 0 |
2.3.1.15 | Breast Neoplasms |
22070544 |
Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling. |
ongoing research unassigned |
2 0 |
2.3.1.15 | Breast Neoplasms |
24967918 |
Glycerol-3-phosphate acyltranferase-2 behaves as a cancer testis gene and promotes growth and tumorigenicity of the breast cancer MDA-MB-231 cell line. |
causal interaction diagnostic usage ongoing research unassigned |
4 3 4 0 |
2.3.1.15 | Breast Neoplasms |
26110566 |
AGPAT9 suppresses cell growth, invasion and metastasis by counteracting acidic tumor microenvironment through KLF4/LASS2/V-ATPase signaling pathway in breast cancer. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 3 2 4 |
2.3.1.15 | Carcinogenesis |
22215515 |
Mice Deficient in Glycerol-3-Phosphate Acyltransferase-1 Have a Reduced Susceptibility to Liver Cancer. |
causal interaction ongoing research therapeutic application unassigned |
3 3 1 0 |
2.3.1.15 | Carcinogenesis |
30813330 |
Transcriptional Regulation of Acyl-CoA:Glycerol-sn-3-Phosphate Acyltransferases. |
causal interaction unassigned |
4 0 |
2.3.1.15 | Carcinoma |
28652252 |
Glycerol-3-phosphate Acyltransferase 1 Promotes Tumor Cell Migration and Poor Survival in Ovarian Carcinoma. |
causal interaction diagnostic usage ongoing research unassigned |
1 4 3 0 |
2.3.1.15 | Carcinoma, Hepatocellular |
6626565 |
An enzymatic rationale for the randomization of the positional distribution of fatty acids in phospholipids of ascites hepatoma AH 130. |
causal interaction diagnostic usage unassigned |
1 1 0 |
2.3.1.15 | Carcinoma, Hepatocellular |
21343633 |
Anthocyanin inhibits high glucose-induced hepatic mtGPAT1 activation and prevents fatty acid synthesis through PKC{zeta} |
causal interaction diagnostic usage ongoing research unassigned |
2 3 4 0 |
2.3.1.15 | Carcinoma, Hepatocellular |
32749667 |
CTRP12 inhibits triglyceride synthesis and export in hepatocytes by suppressing HNF-4? and DGAT2 expression. |
therapeutic application unassigned |
3 0 |